Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications

Brain Tumor Research and Treatment
Yi LiSoonmee Cha

Abstract

Glioblastoma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody against the vascular endothelial growth factor receptor, has increasingly been used in the treatment of recurrent glioblastoma. It has achieved excellent rates of radiographic response, but most patients will progress after only a few months. Upon recurrence, tumors may not enhance, secondary to vascular normalization. We describe four patterns of radiographic progression commonly associated with Bevacizumab failure: 1) Distant enhancing tumor, 2) Local tumor progression without enhancement, 3) Diffuse gliomatosis-like infiltration, and 4) Local or multifocal progression, with enhancement. Some have noted an increased incidence of distant or diffuse disease upon recurrence, suggestive of a transition to a more aggressive phenotype, but a review of the literature suggests there is no conclusive evidence that Bevacizumab treatment is associated with an increased rate of distant or diffuse recurrence.

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Sep 27, 2000·Neoplasia : an International Journal for Oncology Research·J L RubensteinM A Shuman
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 24, 2006·Journal of Neuro-oncology·O KargiotisA P Kyritsis
Aug 26, 2006·Nature Clinical Practice. Neurology·Judith A SchwartzbaumMargaret Wrensch
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James J VredenburghHenry S Friedman
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Dec 18, 2007·International Journal of Cancer. Journal International Du Cancer·An ClaesWilliam Leenders
Mar 11, 2008·Cancer·Felix BoksteinDeborah T Blumenthal
Apr 29, 2008·Journal of Neuro-oncology·Tyler Y KangDavid Peereboom
Jul 4, 2008·Nature Reviews. Cancer·Lee M Ellis, Daniel J Hicklin
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Aug 2, 2008·Journal of Neurosurgery·Sheikh A AliDavid M Friedland
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teri N KreislHoward A Fine
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Jun 19, 2010·Neurosurgery·Eric M ThompsonEdward A Neuwelt
Jan 6, 2011·Neurology·Eric M ThompsonEdward A Neuwelt
Jul 7, 2012·International Journal of Radiation Oncology, Biology, Physics·Lauren Q ShapiroPhilip H Gutin
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark R GilbertMinesh P Mehta

❮ Previous
Next ❯

Citations

Feb 22, 2018·Glia·Valéria Pereira FerrerRolf Mentlein
Jul 30, 2019·Immunological Reviews·David AkhavanChristine E Brown
May 14, 2020·Expert Opinion on Investigational Drugs·Maria B Garcia-FabianiMaria G Castro
May 6, 2020·Scientific Reports·Karthika D SelvasaravananMike-Andrew Westhoff
Sep 14, 2018·International Journal of Molecular Sciences·Ángelo TorresClaudia Quezada
Oct 17, 2020·Neuro-oncology Advances·Kunal S PatelMadhuri Wadehra
Nov 13, 2020·Frontiers in Immunology·Christophe LallemandMichael G Tovey
Nov 11, 2020·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Maruf M HoqueJohn C Chappell
Apr 14, 2020·Advances in Radiation Oncology·Matthew S DietzJerry J Jaboin
Mar 26, 2021·Acta Neuropathologica Communications·Yona KimSun Ha Paek
Apr 9, 2021·British Journal of Cancer·Anette L Magnussen, Ian G Mills
Apr 17, 2020·Life Sciences·Sekaran SaravananVenil N Sumantran
Dec 16, 2021·Journal of Cellular and Molecular Medicine·Michelle ZallesRheal A Towner

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James J VredenburghHenry S Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Annick DesjardinsJames J Vredenburgh
© 2022 Meta ULC. All rights reserved